Authors: Satsuki Komoda Takeshi Komoda Marianne E Pavel Lars Morawietz Bertram Wiedenmann Roland Hetzer Hans B Lehmkuhl
Publish Date: 2011/12/16
Volume: 59, Issue: 12, Pages: 780-785
Abstract
Twelve patients with carcinoid heart diseases underwent cardiac surgery between 2000 and 2008 Patients were divided into two groups group A n = 6 comprised patients who survived more than 6 months after cardiac surgery and group D n = 6 comprised those who died within 6 months Preoperative factors were compared between the groupsAll the 12 patients with carcinoid heart disease underwent tricuspid valve surgery 3 had tricuspid repair and 9 had tricuspid replacement with a bioprosthetic valve Postoperative 30day mortality was 167 and 2year actuarial survival was 500 Median survival after the first diagnosis of carcinoid disease was 44 years that from first diagnosis of carcinoid heart disease was 27 years Preoperative median left ventricular ejection fraction in group D 525 was significantly lower than that in group A 672 P 005 There were no statistically significant differences between the groups in other parametersPostoperative prognosis may be worse when preoperative left ventricular ejection fraction is borderline even if it is within the normal limits Cardiac evaluation is needed in all patients with carcinoid disease from the earliest time of medical and oncological therapy to improve patient outcome
Keywords: